Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
23 hedge funds and large institutions have $3.82M invested in Psychemedics Corporation in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 3 closing their positions.
8% less funds holding
Funds holding: 25 → 23 (-2)
33% less capital invested
Capital invested by funds: $5.68M → $3.82M (-$1.86M)
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$16.7K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.56K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.4K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$352 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell Capital
Alta,
Wyoming
|
-$297K |
| 2 |
WE
Wealth Effects
Boston,
Massachusetts
|
-$162K |
| 3 |
CIC
Crawford Investment Counsel
Atlanta,
Georgia
|
-$32K |
| 4 |
Renaissance Technologies
New York
|
-$21.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$11.3K |
PMD Hedge Fund Activity: Q4 2023 in Review
23 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q4 2023, worth a combined $3.82M — down 33% from $5.68M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PMD and 1 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 6 added.
The largest buyer was Wedbush Securities, adding an estimated $16.7K. The largest seller was Cannell Capital, exiting entirely with an estimated $297K sold.
- 23 institutional investors held Psychemedics Corporation (PMD) as of Q4 2023, down from 25 in Q3 2023.
- Funds reported $3.82M of Psychemedics Corporation stock for Q4 2023, down 33% quarter-over-quarter.
- 1 fund opened new Psychemedics Corporation positions in Q4 2023 and 3 closed out, a net change of -2 holders.
- The largest Psychemedics Corporation buyer in Q4 2023 was Wedbush Securities, an estimated $16.7K added.
- The largest Psychemedics Corporation seller in Q4 2023 was Cannell Capital, an estimated $297K sold.
Based on aggregated 13F filings for Q4 2023.